Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

KORU Medical Systems (KRMD) EBIT Margin (2020 - 2025)

KORU Medical Systems (KRMD) has disclosed EBIT Margin for 10 consecutive years, with 8.34% as the latest value for Q3 2025.

  • On a quarterly basis, EBIT Margin rose 1248.0% to 8.34% in Q3 2025 year-over-year; TTM through Sep 2025 was 10.28%, a 2674.0% decrease, with the full-year FY2024 number at 19.16%, down 2636.0% from a year prior.
  • EBIT Margin was 8.34% for Q3 2025 at KORU Medical Systems, down from 3.07% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 140.9% in Q4 2023 to a low of 55.2% in Q2 2022.
  • A 5-year average of 11.8% and a median of 21.89% in 2021 define the central range for EBIT Margin.
  • Peak YoY movement for EBIT Margin: soared 17509bps in 2023, then crashed -15888bps in 2024.
  • KORU Medical Systems' EBIT Margin stood at 96.34% in 2021, then tumbled by -135bps to 34.19% in 2022, then skyrocketed by 512bps to 140.9% in 2023, then plummeted by -113bps to 17.98% in 2024, then skyrocketed by 54bps to 8.34% in 2025.
  • Per Business Quant, the three most recent readings for KRMD's EBIT Margin are 8.34% (Q3 2025), 3.07% (Q2 2025), and 12.92% (Q1 2025).